2008
DOI: 10.1097/tp.0b013e3181860a74
|View full text |Cite
|
Sign up to set email alerts
|

B Cells in Cluster or in a Scattered Pattern Do Not Correlate With Clinical Outcome of Renal Allograft Rejection

Abstract: A significant correlation was observed between interstitial infiltrates of CD20+ cells and CD3+ cells (r=0.720, P<0.001) suggesting that if B-cell infiltrates are present during rejection, they occur with T-cell infiltrates in a concurrent fashion. In contrast to previous reports, no relation was found between the number of CD20+ cells, in aggregates or in a scattered interstitial pattern, and response to conventional therapy. Remarkably, CD3+T cell aggregates did predict a favorable renal outcome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
45
0
1

Year Published

2009
2009
2022
2022

Publication Types

Select...
3
2
2

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(47 citation statements)
references
References 27 publications
1
45
0
1
Order By: Relevance
“…19 However, other studies showed no associations between CD20-positive cell-rich infiltrates and acute treatmentresistant rejection or unfavorable graft outcomes. 8,9,13 In the present study, CD20-positive cell-enriched infiltrates correlated with immunologic risk factors such as retransplant, higher HLA mismatch, and TCMR, but not with AMR, C4d, DSA, or the risk of graft loss. Factors such as the heterogeneity of the patient population, intensity of immunosuppression, time of post-transplant biopsy, and different methods of defining CD20-positive cells in biopsies might explain the discrepancies between these studies.…”
Section: Discussionmentioning
confidence: 74%
See 2 more Smart Citations
“…19 However, other studies showed no associations between CD20-positive cell-rich infiltrates and acute treatmentresistant rejection or unfavorable graft outcomes. 8,9,13 In the present study, CD20-positive cell-enriched infiltrates correlated with immunologic risk factors such as retransplant, higher HLA mismatch, and TCMR, but not with AMR, C4d, DSA, or the risk of graft loss. Factors such as the heterogeneity of the patient population, intensity of immunosuppression, time of post-transplant biopsy, and different methods of defining CD20-positive cells in biopsies might explain the discrepancies between these studies.…”
Section: Discussionmentioning
confidence: 74%
“…The B cells at different stages of maturation, including immature CD20-positive cells, CD38-positive plasmablasts, and CD138-positive plasma cells, are present in clusters or diffuse infiltrates in grafts during acute rejection and are functionally active. [8][9][10] In acute cellular rejection, the association between B cells, corticosteroid resistance, and poorer graft survival has been shown in some studies, [10][11][12] but these data have not been confirmed in other studies. 8,9,13 The participation of B cells in the humoral immune response also has been investigated.…”
Section: Introductionmentioning
confidence: 76%
See 1 more Smart Citation
“…1 However, these findings are controversial and not in agreement with previous reports. [8][9][10] This variance could be attributed to the use of different criteria for CD20-positive lymphocytic infiltrates, different follow-ups, and differences in study population. In our previous study (unpublished data), we found that the time of those CD20-positive recipients was longer than CD20-negative recipients without statistically significance (145.4 ± 121.2 days vs 75.4 ± 108.8 days, P = .056).…”
Section: Discussionmentioning
confidence: 99%
“…6,7 In contrast, several other reports have demonstrated that CD20 + infiltrates in renal allograft biopsies with ACR are not associated with worse graft survival. [8][9][10] Therefore, the relation between CD20 + cell infiltration and outcomes of renal allograft is controversial.…”
Section: Introductionmentioning
confidence: 99%